J.R. Boot

672 total citations
21 papers, 523 citations indexed

About

J.R. Boot is a scholar working on Physiology, Pharmacology and Organic Chemistry. According to data from OpenAlex, J.R. Boot has authored 21 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 7 papers in Pharmacology and 4 papers in Organic Chemistry. Recurrent topics in J.R. Boot's work include Asthma and respiratory diseases (10 papers), Inflammatory mediators and NSAID effects (7 papers) and Neuroscience and Neuropharmacology Research (2 papers). J.R. Boot is often cited by papers focused on Asthma and respiratory diseases (10 papers), Inflammatory mediators and NSAID effects (7 papers) and Neuroscience and Neuropharmacology Research (2 papers). J.R. Boot collaborates with scholars based in United Kingdom, United States and India. J.R. Boot's co-authors include W Dawson, Anthony F. Cockerill, David N. B. Mallen, David J. Osborne, E Kitchen, Bethan Lang, Richard Webster, Emanuele Sher, John R. Walker and Peter C. Astles and has published in prestigious journals such as Nature, British Journal of Pharmacology and European Journal of Pharmacology.

In The Last Decade

J.R. Boot

21 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.R. Boot United Kingdom	11	247	159	155	107	63	21	523
尚三山本	3	151 0.6×	143 0.9×	137 0.9×	86 0.8×	34 0.5×	3	555
B Panczenko United States	6	307 1.2×	110 0.7×	166 1.1×	114 1.1×	50 0.8×	11	547
G.C. Folco Italy	12	140 0.6×	115 0.7×	216 1.4×	77 0.7×	19 0.3×	27	496
Hiromi Sugimoto Japan	12	130 0.5×	185 1.2×	186 1.2×	39 0.4×	23 0.4×	23	525
Mary G. Huber United States	7	107 0.4×	137 0.9×	125 0.8×	50 0.5×	19 0.3×	9	393
Marwa N. Samhoun United Kingdom	12	174 0.7×	136 0.9×	428 2.8×	93 0.9×	17 0.3×	19	674
Colleen P. Gibbons United States	4	316 1.3×	156 1.0×	54 0.3×	67 0.6×	35 0.6×	4	522
Sandra F. Falkenhein United States	9	120 0.5×	126 0.8×	194 1.3×	85 0.8×	18 0.3×	13	452
Barry Cooper United States	13	182 0.7×	259 1.6×	137 0.9×	58 0.5×	21 0.3×	18	697
F. B. Ubatuba United Kingdom	10	202 0.8×	145 0.9×	80 0.5×	161 1.5×	19 0.3×	15	573

Countries citing papers authored by J.R. Boot

Since Specialization

Citations

This map shows the geographic impact of J.R. Boot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.R. Boot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.R. Boot more than expected).

Fields of papers citing papers by J.R. Boot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.R. Boot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.R. Boot. The network helps show where J.R. Boot may publish in the future.

Co-authorship network of co-authors of J.R. Boot

This figure shows the co-authorship network connecting the top 25 collaborators of J.R. Boot. A scholar is included among the top collaborators of J.R. Boot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.R. Boot. J.R. Boot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boot, J.R., et al.. (2004). Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin and norepinephrine reuptake. Bioorganic & Medicinal Chemistry Letters. 14(21). 5395–5399. 16 indexed citations

Sher, Emanuele, et al.. (2002). Calcium channel subtypes contributing to acetylcholine release from normal, 4‐aminopyridine‐treated and myasthenic syndrome auto‐antibodies‐affected neuromuscular junctions. British Journal of Pharmacology. 136(8). 1135–1145. 49 indexed citations

Astles, Peter C., et al.. (2002). Recent Progress in the Development of Subtype Selective Nicotinic Acetylcholine Receptor Ligands. PubMed. 1(4). 337–348. 39 indexed citations

Boot, J.R., et al.. (1997). Pharmacological studies using human voltage-dependent calcium channels. 89. 1 indexed citations

Bond, Ann & J.R. Boot. (1992). The effect of calcium channel modulators on blood pressure and pressor responses to noradrenaline in the guinea-pig. European Journal of Pharmacology. 218(1). 179–181. 10 indexed citations

Boot, J.R., et al.. (1991). The Relationship between Development of Lung Inflammation and Changes in Bone Marrow Populations in Guinea-Pigs following Inhaled Antigen Challenge. International Archives of Allergy and Immunology. 96(1). 1–11. 9 indexed citations

Baker, Stephen, et al.. (1990). The pharmacology of N-methyl LTC4; a metabolically stable LTC4-mimetic. Prostaglandins. 40(5). 445–461. 3 indexed citations

Boot, J.R., et al.. (1989). The pharmacological evaluation of LY170680, a novel leukotriene D₄and E₄antagonist in the guinea‐pig. British Journal of Pharmacology. 98(1). 259–267. 11 indexed citations

Baker, Stephen, et al.. (1984). Some β-hydroxy-sulphides as leukotriene D4 antagonists. Prostaglandins. 28(5). 655–655. 2 indexed citations

10.

Ho, P. P. K., et al.. (1983). The preferential inhibition of 5-lipoxygenase product formation by benoxaprofen. Journal of Pharmacy and Pharmacology. 35(1). 44–45. 26 indexed citations

11.

Boot, J.R., et al.. (1982). The Anti-Allergic Activity of Benoxaprofen [2-(4-Chlorophenyl)-α-Methyl-5-Benzoxazole Acetic Acid] – A Lipoxygenase Inhibitor. International Archives of Allergy and Immunology. 67(4). 340–343. 14 indexed citations

12.

Walker, John R., et al.. (1980). Inhibition of the release of slow-reacting substance of anaphylaxis by inhibitors of lipoxygenase activity. Journal of Pharmacy and Pharmacology. 32(1). 866–867. 33 indexed citations

13.

Boot, J.R., B N Hudspith, & Jonathan Brostoff. (1980). The effect of the major mediators of type I hypersensitivity on lymphocytes from normal and atopic subjects. International Journal of Immunopharmacology. 2(1). 7–11. 7 indexed citations

14.

Osborne, David J., J.R. Boot, Anthony F. Cockerill, et al.. (1979). PGE1 metabolism by the perfused rat liver. Prostaglandins. 17(6). 863–872. 10 indexed citations

15.

Kitchen, E, J.R. Boot, & W Dawson. (1978). Chemotactic activity of thromboxane B2, prostaglandins and their metabolites for polymorphonuclear leucocytes. Prostaglandins. 16(2). 239–244. 63 indexed citations

16.

Boot, J.R., Anthony F. Cockerill, W Dawson, David N. B. Mallen, & David J. Osborne. (1978). Modification of Prostaglandin and Thromboxane Release by Immunological Sensitisation and Successive Immunological Challenges from Guinea-Pig Lung. International Archives of Allergy and Immunology. 57(2). 159–164. 28 indexed citations

17.

Boot, J.R., et al.. (1977). The relationship between prostaglandin-like substances and SRS-A released from immunologically challenged lungs [proceedings].. PubMed. 59(3). 444P–445P. 3 indexed citations

18.

Boot, J.R., W Dawson, Anthony F. Cockerill, David N. B. Mallen, & David J. Osborne. (1977). The pharmacology of prostaglandin-like substances released from guinea-pig lungs during anaphylaxis. Prostaglandins. 13(5). 927–932. 18 indexed citations

19.

Dawson, W, J.R. Boot, Anthony F. Cockerill, David N. B. Mallen, & David J. Osborne. (1976). Release of novel prostaglandins and thromboxanes after immunological challenge of guinea pig lung. Nature. 262(5570). 699–702. 163 indexed citations

20.

Boot, J.R., et al.. (1974). Synthesis of two PGE2 human urinary metabolites. Prostaglandins. 8(5). 439–446. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact